Real‐life efficacy and safety of secukinumab in elderly patients with psoriasis over a 2‐year period

Abstract

Secukinumab seems to be a safe and effective treatment for elderly patients with psoriasis, who frequently have multiple comorbidities, polypharmacy and multiple failures with previous systemic treatments including biologics.